In this column for Bioanalysis Zone, BioAgilytix’s Global Chief Scientific Officer, Dr. Afshin Safavi, discusses how applying the concepts of ‘fit-for-purpose’ (FFP) and ‘context of use’ (COU) can help in constructing biomarker assays that adequately meet investigation goals.
Click for full article
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Services
Platforms